RecruitingNot ApplicableNCT07276815

OverStitch NXT Endoscopic Suture System

Gathering of Results in Eligible Asian Obese Populations About Safety and Effectiveness of Overstitch ESG Trial

Sponsor

Boston Scientific Corporation

Enrollment

136 participants

Start Date

Aug 6, 2026

Study Type

INTERVENTIONAL

Conditions

Weight Loss

Summary

To demonstrate the safety and efficacy of OverStitch NXT Endoscopic Suture System for endoscopic sleeve gastroplasty（ESG） in obese populations to support the registration of OverStitch NXT for ESG indication.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called OverStitch NXT Endoscopic Suture System for people with weight loss. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOverStitch NXT Endoscopic Suture System

The OverStitch NXT Endoscopic Suture System is indicated for the endoscopic placement of anchor-sutures. Anchor sutures can be placed for endoscopic sleeve gastroplasty（ESG）.